Insulinlike androgenic hormones and monosex culture of prawns

  • Slides: 13
Download presentation
Insulin-like androgenic hormones and monosex culture of prawns: The first implementation of RNA-interference RNA-i

Insulin-like androgenic hormones and monosex culture of prawns: The first implementation of RNA-interference RNA-i in aquaculture Amir Sagi Ben-Gurion University of the Negev, Israel

M. rosenbergii dimorphic growth pattern in favor of males Cumulative Weight (g/2 m 2)

M. rosenbergii dimorphic growth pattern in favor of males Cumulative Weight (g/2 m 2) 1000 800 & 600 400 ~60% higher income Field study in India Nair et al. , 2006 200 0 45 60 75 88 102 115 130 142 152 2 cm * Includes only the marketable yields (≥ 30 g) Time (days) Modified from Sagi et al. , 1986 Aquacult.

Mr-IAG silencing induces full functional sex reversal 1 cm 3 mm ♂♀ n. c.

Mr-IAG silencing induces full functional sex reversal 1 cm 3 mm ♂♀ n. c. of em al F 1 (control female progeny) Ne Co ♂ ♀ nt fe rol m al e e Female specific sex marker F 1 (neo-female progeny) n. c. P. C. F. S. Ventura et al. , Heredity, 2011

IAG silencing and prawn monosex biotechnologial cascade WZ X 50% WZ ZZ 50% ZZ

IAG silencing and prawn monosex biotechnologial cascade WZ X 50% WZ ZZ 50% ZZ RNAi IAG Neo ZZ X 100% Modified from Aflalo et al. , 2006 Aquacult ZZ ZZ

Monosex all-male culture The androgenic gland Sex differentiation Insulin-like Patent: RNA silencing of insulin-like

Monosex all-male culture The androgenic gland Sex differentiation Insulin-like Patent: RNA silencing of insulin-like gene in prawn and uses thereof. PCT/IL 2009/000127 (priority: February 4, 2008) WO 2009/098683, US 2012/073508. Biotechnology

How is RNAi working (non GMO) Mr-IAG Insulin-like androgenic hormone RNA Temporal ds. RNA

How is RNAi working (non GMO) Mr-IAG Insulin-like androgenic hormone RNA Temporal ds. RNA effect 5’- A U CU U G C A U C C G C C U U G C A A U U A A AA UU GG CC AA UU GG A A A A 3’- 5’- U A UC A A C C U A C G U A UU UU AA CC GG UU AA C DNA A gene encoding the 3’Insulin like androgenic hormone A T G C A T A A T G C A T C C T G C A T A C G T A T T A C G T A C G T A T -5’ -3’

Clearance of exogenous ds. RNA in injected prawns 7 Time (Days) 7 days 3

Clearance of exogenous ds. RNA in injected prawns 7 Time (Days) 7 days 3 3 days Controls PC NC T 0 T 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 14 14 days 17 18 19 20 21 22 23 24

RNAi temporarily reduces Mr-IAG expression Real time RT-PCR Relative Mr-IAG expression (%) 100 90

RNAi temporarily reduces Mr-IAG expression Real time RT-PCR Relative Mr-IAG expression (%) 100 90 80 70 60 50 40 30 20 10 0 Control 3 21 Days after ds. Mr-IAG injection 28

Neo females (sex reversed males) reproductive performance Females Neo females Body weight (g) 32.

Neo females (sex reversed males) reproductive performance Females Neo females Body weight (g) 32. 03 ± 0. 28 41. 31 ± 0. 22 BSI (%) 13. 3 ± 1. 63 12. 7 ± 1. 28 Eggs/g BW 859 ± 120 845 ± 67

Selective breeding scheme combined with all-male selective production Local strain BGU line 1 st

Selective breeding scheme combined with all-male selective production Local strain BGU line 1 st Generation BGU line Neo female Selected Local strain All-male PLs to growers G 1 2 nd Generation BGU line Neo female G 2 Modified from Aflalo et al. , 2012 Selected Local strain All-male PLs to growers G 2

Recommendations • Protect from decay by crossing BGU with Local lines (do not reuse

Recommendations • Protect from decay by crossing BGU with Local lines (do not reuse crosses, no backflow of genes). • Insert a selectively bred line into the portfolio (improved lines in Vietnam, India, or other sources). • Pathogen free declaration of the BGU line.

Up to this point, the technology Temporal RNAi No hormone treatment No chemicals Non

Up to this point, the technology Temporal RNAi No hormone treatment No chemicals Non GMO Price Delivery 17. 8 B $ Environmental Solutions Bio-control Aquaculture production enhancement 5. 4 B $

Thank you Dr. Tomer Ventura Ohad Rosen Dr. Simy Weill Dr. Ziv Roth Dr.

Thank you Dr. Tomer Ventura Ohad Rosen Dr. Simy Weill Dr. Ziv Roth Dr. Eli D. Aflalo Yaara Lazar Dr. Rivka Manor Omri Sharabi Dr. Lilah Glazer Funding sources: BARD TIRAN Shipping Ltd.